Cargando…
Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
Resolution Pharmacology identifies drugs developed on the biology of the resolution phase of inflammation, the complex molecular and cellular network of events that ensure the tight temporal and spatial control on the inflammatory response. As such, new anti-inflammatory and pro-resolving drugs coul...
Autores principales: | Patruno, Sara, Garrido-Mesa, Jose, Romano, Mario, Perretti, Mauro, Montero-Melendez, Trinidad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102781/ https://www.ncbi.nlm.nih.gov/pubmed/30154720 http://dx.doi.org/10.3389/fphar.2018.00919 |
Ejemplares similares
-
Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177
por: Garrido-Mesa, Jose, et al.
Publicado: (2022) -
Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides
por: Ahmed, Tazeen J., et al.
Publicado: (2013) -
Melanocortin Receptors as Novel Effectors of Macrophage Responses in Inflammation
por: Patel, Hetal B., et al.
Publicado: (2011) -
Melanocortin therapies to resolve fibroblast-mediated diseases
por: Khodeneva, Natalya, et al.
Publicado: (2023) -
Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3
por: Montero-Melendez, Trinidad, et al.
Publicado: (2016)